Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 673 to 682 of 682 entries
Sorted by: Best Match Show Resources per page
Characterization of the blood microbiota in children with Celiac disease.

Current research in microbial sciences

Mehrotra I, Serena G, Cetinbas M, Kenyon V, Martin VM, Harshman SG, Zomorrodi AR, Sadreyev RI, Fasano A, Leonard MM.
PMID: 34841359
Curr Res Microb Sci. 2021 Aug 30;2:100069. doi: 10.1016/j.crmicr.2021.100069. eCollection 2021 Dec.

Celiac Disease (CD) is an autoimmune disorder triggered by gluten ingestion that can develop in genetically predisposed individuals. Alterations in the gut microbiota have been suggested to contribute to development of autoimmune conditions including CD. Recent work suggests the...

Cite
Mehrotra I, Serena G, Cetinbas M, et al. Characterization of the blood microbiota in children with Celiac disease. Curr Res Microb Sci. 2021;2:100069doi: 10.1016/j.crmicr.2021.100069.
Mehrotra, I., Serena, G., Cetinbas, M., Kenyon, V., Martin, V. M., Harshman, S. G., Zomorrodi, A. R., Sadreyev, R. I., Fasano, A., & Leonard, M. M. (2021). Characterization of the blood microbiota in children with Celiac disease. Current research in microbial sciences, 2100069. https://doi.org/10.1016/j.crmicr.2021.100069
Mehrotra, Isha, et al. "Characterization of the blood microbiota in children with Celiac disease." Current research in microbial sciences vol. 2 (2021): 100069. doi: https://doi.org/10.1016/j.crmicr.2021.100069
Mehrotra I, Serena G, Cetinbas M, Kenyon V, Martin VM, Harshman SG, Zomorrodi AR, Sadreyev RI, Fasano A, Leonard MM. Characterization of the blood microbiota in children with Celiac disease. Curr Res Microb Sci. 2021 Aug 30;2:100069. doi: 10.1016/j.crmicr.2021.100069. eCollection 2021 Dec. PMID: 34841359; PMCID: PMC8610358.
Copy Download .nbib Format: NLM
Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act.

Journal of general internal medicine

Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A.
PMID: 34713386
J Gen Intern Med. 2022 Jan;37(1):162-167. doi: 10.1007/s11606-021-07174-w. Epub 2021 Oct 28.

BACKGROUND: The Ryan Haight Act generally requires a clinician to conduct an in-person visit before prescribing an opioid use disorder (OUD) medication. This requirement has impeded use of telemedicine to expand OUD treatment, and many policymakers have called for...

Cite
Huskamp HA, Riedel L, Uscher-Pines L, et al. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. J Gen Intern Med. 2021;37(1):162-167doi: 10.1007/s11606-021-07174-w.
Huskamp, H. A., Riedel, L., Uscher-Pines, L., Busch, A. B., Barnett, M. L., Raja, P., & Mehrotra, A. (2022). Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. Journal of general internal medicine, 37(1), 162-167. https://doi.org/10.1007/s11606-021-07174-w
Huskamp, Haiden A, et al. "Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act." Journal of general internal medicine vol. 37,1 (2022): 162-167. doi: https://doi.org/10.1007/s11606-021-07174-w
Huskamp HA, Riedel L, Uscher-Pines L, Busch AB, Barnett ML, Raja P, Mehrotra A. Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act. J Gen Intern Med. 2022 Jan;37(1):162-167. doi: 10.1007/s11606-021-07174-w. Epub 2021 Oct 28. PMID: 34713386; PMCID: PMC8553288.
Copy Download .nbib Format: NLM
ProBlock: a novel approach for fake news detection.

Cluster computing

Sengupta E, Nagpal R, Mehrotra D, Srivastava G.
PMID: 34366702
Cluster Comput. 2021 Aug 04;1-17. doi: 10.1007/s10586-021-03361-w. Epub 2021 Aug 04.

The world is diving deeper into the digital age, and the sources of first information are moving towards social media and online news portals. The chances of being misinformed increase multifold as our reliance on sources of information are...

Cite
Sengupta E, Nagpal R, Mehrotra D, et al. ProBlock: a novel approach for fake news detection. Cluster Comput. 2021;1-17doi: 10.1007/s10586-021-03361-w.
Sengupta, E., Nagpal, R., Mehrotra, D., & Srivastava, G. (2021). ProBlock: a novel approach for fake news detection. Cluster computing, 1-17. https://doi.org/10.1007/s10586-021-03361-w
Sengupta, Eishvak, et al. "ProBlock: a novel approach for fake news detection." Cluster computing vol. (2021): 1-17. doi: https://doi.org/10.1007/s10586-021-03361-w
Sengupta E, Nagpal R, Mehrotra D, Srivastava G. ProBlock: a novel approach for fake news detection. Cluster Comput. 2021 Aug 04;1-17. doi: 10.1007/s10586-021-03361-w. Epub 2021 Aug 04. PMID: 34366702; PMCID: PMC8335474.
Copy Download .nbib Format: NLM
Tobacco use as a well-recognized cause of severe COVID-19 manifestations.

Respiratory medicine

Gupta AK, Nethan ST, Mehrotra R.
PMID: 33253975
Respir Med. 2021 Jan;176:106233. doi: 10.1016/j.rmed.2020.106233. Epub 2020 Nov 19.

INTRODUCTION: The Coronavirus disease (COVID-19) infection is caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) primarily affecting the lungs. All tobacco-related illnesses including asthma, chronic obstructive pulmonary disease (COPD), and coronary artery disease are known to reduce...

Cite
Gupta AK, Nethan ST, Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respir Med. 2020;176:106233doi: 10.1016/j.rmed.2020.106233.
Gupta, A. K., Nethan, S. T., & Mehrotra, R. (2021). Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respiratory medicine, 176106233. https://doi.org/10.1016/j.rmed.2020.106233
Gupta, Alpana Kumar, et al. "Tobacco use as a well-recognized cause of severe COVID-19 manifestations." Respiratory medicine vol. 176 (2021): 106233. doi: https://doi.org/10.1016/j.rmed.2020.106233
Gupta AK, Nethan ST, Mehrotra R. Tobacco use as a well-recognized cause of severe COVID-19 manifestations. Respir Med. 2021 Jan;176:106233. doi: 10.1016/j.rmed.2020.106233. Epub 2020 Nov 19. PMID: 33253975; PMCID: PMC7674071.
Copy Download .nbib Format: NLM
Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review.

Journal of migration and health

Hayward SE, Deal A, Cheng C, Crawshaw A, Orcutt M, Vandrevala TF, Norredam M, Carballo M, Ciftci Y, Requena-Méndez A, Greenaway C, Carter J, Knights F, Mehrotra A, Seedat F, Bozorgmehr K, Veizis A, Campos-Matos I, Wurie F, McKee M, Kumar B, Hargreaves S.
PMID: 33903857
J Migr Health. 2021;3:100041. doi: 10.1016/j.jmh.2021.100041. Epub 2021 Apr 22.

BACKGROUND: Migrants in high-income countries may be at increased risk of COVID-19 due to their health and social circumstances, yet the extent to which they are affected and their predisposing risk factors are not clearly understood. We did a...

Cite
Hayward SE, Deal A, Cheng C, et al. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. J Migr Health. 2021;3:100041doi: 10.1016/j.jmh.2021.100041.
Hayward, S. E., Deal, A., Cheng, C., Crawshaw, A., Orcutt, M., Vandrevala, T. F., Norredam, M., Carballo, M., Ciftci, Y., Requena-Méndez, A., Greenaway, C., Carter, J., Knights, F., Mehrotra, A., Seedat, F., Bozorgmehr, K., Veizis, A., Campos-Matos, I., Wurie, F., McKee, M., Kumar, B., Hargreaves, S. (2021). Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. Journal of migration and health, 3100041. https://doi.org/10.1016/j.jmh.2021.100041
Hayward, Sally E, et al. "Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review." Journal of migration and health vol. 3 (2021): 100041. doi: https://doi.org/10.1016/j.jmh.2021.100041
Hayward SE, Deal A, Cheng C, Crawshaw A, Orcutt M, Vandrevala TF, Norredam M, Carballo M, Ciftci Y, Requena-Méndez A, Greenaway C, Carter J, Knights F, Mehrotra A, Seedat F, Bozorgmehr K, Veizis A, Campos-Matos I, Wurie F, McKee M, Kumar B, Hargreaves S. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. J Migr Health. 2021;3:100041. doi: 10.1016/j.jmh.2021.100041. Epub 2021 Apr 22. PMID: 33903857; PMCID: PMC8061095.
Copy Download .nbib Format: NLM
Patient Experience of Obstetric Care During the COVID-19 Pandemic: Preliminary Results From a Recurring National Survey.

Journal of patient experience

Bradley D, Blaine A, Shah N, Mehrotra A, Gupta R, Wolfberg A.
PMID: 33294594
J Patient Exp. 2020 Oct;7(5):653-656. doi: 10.1177/2374373520964045. Epub 2020 Oct 06.

The experience of pregnant and postpartum patients continues to evolve during the COVID-19 pandemic. Limited clinical data and the unknown nature of the virus' impact and transmission routes have forced constant changes to traditional care delivery. Dependence on telehealth...

Cite
Bradley D, Blaine A, Shah N, et al. Patient Experience of Obstetric Care During the COVID-19 Pandemic: Preliminary Results From a Recurring National Survey. J Patient Exp. 2020;7(5):653-656doi: 10.1177/2374373520964045.
Bradley, D., Blaine, A., Shah, N., Mehrotra, A., Gupta, R., & Wolfberg, A. (2020). Patient Experience of Obstetric Care During the COVID-19 Pandemic: Preliminary Results From a Recurring National Survey. Journal of patient experience, 7(5), 653-656. https://doi.org/10.1177/2374373520964045
Bradley, Dani, et al. "Patient Experience of Obstetric Care During the COVID-19 Pandemic: Preliminary Results From a Recurring National Survey." Journal of patient experience vol. 7,5 (2020): 653-656. doi: https://doi.org/10.1177/2374373520964045
Bradley D, Blaine A, Shah N, Mehrotra A, Gupta R, Wolfberg A. Patient Experience of Obstetric Care During the COVID-19 Pandemic: Preliminary Results From a Recurring National Survey. J Patient Exp. 2020 Oct;7(5):653-656. doi: 10.1177/2374373520964045. Epub 2020 Oct 06. PMID: 33294594; PMCID: PMC7705828.
Copy Download .nbib Format: NLM
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.

NPJ breast cancer

El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S.
PMID: 34853355
NPJ Breast Cancer. 2021 Dec 01;7(1):150. doi: 10.1038/s41523-021-00346-1.

The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients...

Cite
El Bairi K, Haynes HR, Blackley E, et al. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer. 2021;7(1):150doi: 10.1038/s41523-021-00346-1.
El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., Kallala, A., Arun, I., Azmoudeh-Ardalan, F., Fujimoto, L., Sua, L. F., Liu, S. W., Lien, H. C., Kirtani, P., Balancin, M., El Attar, H., Guleria, P., Yang, W., Shash, E., Chen, I. C., Bautista, V., Do Prado Moura, J. F., Rapoport, B. L., Castaneda, C., Spengler, E., Acosta-Haab, G., Frahm, I., Sanchez, J., Castillo, M., Bouchmaa, N., Md Zin, R. R., Shui, R., Onyuma, T., Yang, W., Husain, Z., Willard-Gallo, K., Coosemans, A., Perez, E. A., Provenzano, E., Ericsson, P. G., Richardet, E., Mehrotra, R., Sarancone, S., Ehinger, A., Rimm, D. L., Bartlett, J. M. S., Viale, G., Denkert, C., Hida, A. I., Sotiriou, C., Loibl, S., Hewitt, S. M., Badve, S., Symmans, W. F., Kim, R. S., Pruneri, G., Goel, S., Francis, P. A., Inurrigarro, G., Yamaguchi, R., Garcia-Rivello, H., Horlings, H., Afqir, S., Salgado, R., Adams, S., Kok, M., Dieci, M. V., Michiels, S., Demaria, S., Loi, S. (2021). The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ breast cancer, 7(1), 150. https://doi.org/10.1038/s41523-021-00346-1
El Bairi, Khalid, et al. "The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group." NPJ breast cancer vol. 7,1 (2021): 150. doi: https://doi.org/10.1038/s41523-021-00346-1
El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer. 2021 Dec 01;7(1):150. doi: 10.1038/s41523-021-00346-1. PMID: 34853355; PMCID: PMC8636568.
Copy Download .nbib Format: NLM
Patient specific total temporomandibular joint reconstruction: A review of biomaterial, designs, fabrication and outcomes.

Journal of oral biology and craniofacial research

Mehrotra D, Kumar S, Mehrotra P, Khanna R, Khanna V, Eggbeer D, Evans P.
PMID: 33786297
J Oral Biol Craniofac Res. 2021 Apr-Jun;11(2):334-343. doi: 10.1016/j.jobcr.2021.02.014. Epub 2021 Mar 10.

PURPOSE: The aim of this article was to systematically review the available literature on patient specific total temporomandibular joint total joint replacement (PS-TMJR) implants for their biomaterial, designs, fabrication techniques and their outcomes.METHODS: A literature review was conducted using...

Cite
Mehrotra D, Kumar S, Mehrotra P, et al. Patient specific total temporomandibular joint reconstruction: A review of biomaterial, designs, fabrication and outcomes. J Oral Biol Craniofac Res. 2021;11(2):334-343doi: 10.1016/j.jobcr.2021.02.014.
Mehrotra, D., Kumar, S., Mehrotra, P., Khanna, R., Khanna, V., Eggbeer, D., & Evans, P. (2021). Patient specific total temporomandibular joint reconstruction: A review of biomaterial, designs, fabrication and outcomes. Journal of oral biology and craniofacial research, 11(2), 334-343. https://doi.org/10.1016/j.jobcr.2021.02.014
Mehrotra, Divya, et al. "Patient specific total temporomandibular joint reconstruction: A review of biomaterial, designs, fabrication and outcomes." Journal of oral biology and craniofacial research vol. 11,2 (2021): 334-343. doi: https://doi.org/10.1016/j.jobcr.2021.02.014
Mehrotra D, Kumar S, Mehrotra P, Khanna R, Khanna V, Eggbeer D, Evans P. Patient specific total temporomandibular joint reconstruction: A review of biomaterial, designs, fabrication and outcomes. J Oral Biol Craniofac Res. 2021 Apr-Jun;11(2):334-343. doi: 10.1016/j.jobcr.2021.02.014. Epub 2021 Mar 10. PMID: 33786297; PMCID: PMC7994537.
Copy Download .nbib Format: NLM
Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population.

Human immunology

Thakur N, Kumar Pandey R, Kumar V, Mannan R, Pruthi A, Mehrotra S.
PMID: 34301420
Hum Immunol. 2021 Oct;82(10):791-797. doi: 10.1016/j.humimm.2021.06.009. Epub 2021 Jul 21.

BACKGROUND: IL6 is an important candidate gene implicated in the pathogenesis of glaucoma. The present study assessed the genetic association of -174G > C and -572G > C polymorphisms in the IL6 promoter region with primary open angle glaucoma...

Cite
Thakur N, Kumar Pandey R, Kumar V, et al. Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population. Hum Immunol. 2021;82(10):791-797doi: 10.1016/j.humimm.2021.06.009.
Thakur, N., Kumar Pandey, R., Kumar, V., Mannan, R., Pruthi, A., & Mehrotra, S. (2021). Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population. Human immunology, 82(10), 791-797. https://doi.org/10.1016/j.humimm.2021.06.009
Thakur, Nanamika, et al. "Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population." Human immunology vol. 82,10 (2021): 791-797. doi: https://doi.org/10.1016/j.humimm.2021.06.009
Thakur N, Kumar Pandey R, Kumar V, Mannan R, Pruthi A, Mehrotra S. Suggestive evidence of genetic association of -572G > C polymorphism with primary open angle glaucoma in a North Indian Punjabi population. Hum Immunol. 2021 Oct;82(10):791-797. doi: 10.1016/j.humimm.2021.06.009. Epub 2021 Jul 21. PMID: 34301420.
Copy Download .nbib Format: NLM
Computed tomographic analysis of cervical spine pedicles in the adult Indian population.

Surgical neurology international

Kumar S, Saini NK, Singh D, Chadha M, Mehrotra G.
PMID: 33767872
Surg Neurol Int. 2021 Feb 23;12:68. doi: 10.25259/SNI_926_2020. eCollection 2021.

BACKGROUND: Cervical pedicle screw insertion is a technically demanding procedure that carries the risk of catastrophic damage to surrounding neurovascular structures. Here, we analyzed computed tomography (CT)-based three-dimensional cervical spine pedicle geometry to determine the level and sex-specific morphologic...

Cite
Kumar S, Saini NK, Singh D, et al. Computed tomographic analysis of cervical spine pedicles in the adult Indian population. Surg Neurol Int. 2021;12:68doi: 10.25259/SNI_926_2020.
Kumar, S., Saini, N. K., Singh, D., Chadha, M., & Mehrotra, G. (2021). Computed tomographic analysis of cervical spine pedicles in the adult Indian population. Surgical neurology international, 1268. https://doi.org/10.25259/SNI_926_2020
Kumar, Sanjeev, et al. "Computed tomographic analysis of cervical spine pedicles in the adult Indian population." Surgical neurology international vol. 12 (2021): 68. doi: https://doi.org/10.25259/SNI_926_2020
Kumar S, Saini NK, Singh D, Chadha M, Mehrotra G. Computed tomographic analysis of cervical spine pedicles in the adult Indian population. Surg Neurol Int. 2021 Feb 23;12:68. doi: 10.25259/SNI_926_2020. eCollection 2021. PMID: 33767872; PMCID: PMC7982095.
Copy Download .nbib Format: NLM
Showing 673 to 682 of 682 entries